These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10089049)

  • 1. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
    Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
    J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.
    Fabris P; Biasin MR; Infantolino D; Romanó L; Benedetti P; Tositti G; Pellizzer GP; Zanetti AR; Stecca C; Marchelle G; de Lalla F
    Infection; 1998; 26(5):283-7. PubMed ID: 9795785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
    Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
    J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBV-C/HGV infection in children with chronic hepatitis C.
    Komatsu H; Fujisawa T; Inui A; Sogo T; Morinishi Y; Miyagawa Y; Inui M
    J Med Virol; 1999 Oct; 59(2):154-9. PubMed ID: 10459149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy.
    Oshita M; Hayashi N; Mita E; Iio S; Hiramatsu N; Hijioka T; Kato M; Masuzawa M; Sasaki Y; Kasahara A; Hori M
    J Med Virol; 1998 Jun; 55(2):98-102. PubMed ID: 9598928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis.
    Francesconi R; Giostra F; Ballardini G; Manzin A; Solforosi L; Lari F; Descovich C; Ghetti S; Grassi A; Bianchi G; Zauli D; Clementi M; Bianchi FB
    J Hepatol; 1997 Jun; 26(6):1165-72. PubMed ID: 9210600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
    Kao JH; Lai MY; Chen W; Chen PJ; Chen DS
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1249-53. PubMed ID: 9918434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of GB virus C/hepatitis G virus-RNA and anti-envelope antibody in high-risk populations in Taiwan.
    Hwang SJ; Chu CW; Lu RH; Lan KH; Wu JC; Wang YJ; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1171-5. PubMed ID: 11106098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
    Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
    Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy.
    Fujisawa T; Horiike N; Michitaka K; Onji M
    J Gastroenterol Hepatol; 2000 Jun; 15(6):632-9. PubMed ID: 10921417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
    Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
    J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.
    Jarvis LM; Bell H; Simmonds P; Hawkins A; Hellum K; Harthug S; Maeland A; Ritland S; Myrvang B; von der Lippe B; Raknerud N; Skaug K
    Scand J Gastroenterol; 1998 Feb; 33(2):195-200. PubMed ID: 9517532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients.
    Okuda M; Hino K; Korenaga M; Yamaguchi Y; Katoh Y; Mukaide M; Kaneda Y; Minaminozono T; Okita K
    J Clin Gastroenterol; 2000 Jun; 30(4):425-8. PubMed ID: 10875473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.